| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.045 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |